Financial reports
10-K
2023 FY
Annual report
19 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
25 Apr 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
1 Mar 22
Current reports
8-K
Precigen Reports Full Year 2023 Financial Results and Business Updates
19 Mar 24
8-K
Departure of Directors or Certain Officers
8 Feb 24
8-K
Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference
8 Jan 24
8-K
Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs
9 Nov 23
8-K
Results of Operations and Financial Condition
9 Aug 23
8-K
Departure of Directors or Certain Officers
9 Jun 23
8-K
Precigen Reports First Quarter 2023 Financial Results and Business Updates
10 May 23
8-K
Entry into a Material Definitive Agreement
4 Apr 23
8-K
Regulation FD Disclosure
13 Mar 23
8-K
Precigen Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
6 Mar 23
Registration and prospectus
S-3
Shelf registration
29 Dec 23
S-8
Registration of securities for employees
6 Jul 23
424B5
Prospectus supplement for primary offering
25 Jan 23
424B5
Prospectus supplement for primary offering
24 Jan 23
424B5
Prospectus supplement for primary offering
9 Aug 22
424B5
Prospectus supplement for primary offering
22 Jan 21
424B5
Prospectus supplement for primary offering
21 Jan 21
D
$13M in equity, sold $13M, 2 investors
17 Dec 20
S-3
Shelf registration
30 Sep 20
S-8
Registration of securities for employees
22 Jun 20
Proxies
DEFA14A
Additional proxy soliciting materials
25 Apr 23
DEF 14A
Definitive proxy
25 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEFA14A
Additional proxy soliciting materials
28 Apr 21
DEF 14A
Definitive proxy
28 Apr 21
DEFA14A
Additional proxy soliciting materials
4 Jun 20
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
Other
EFFECT
Notice of effectiveness
18 Jan 24
CORRESP
Correspondence with SEC
12 Jan 24
UPLOAD
Letter from SEC
4 Jan 24
EFFECT
Notice of effectiveness
13 Oct 20
CORRESP
Correspondence with SEC
7 Oct 20
UPLOAD
Letter from SEC
2 Oct 20
EFFECT
Notice of effectiveness
6 Jul 20
UPLOAD
Letter from SEC
30 Jun 20
CORRESP
Correspondence with SEC
30 Jun 20
UPLOAD
Letter from SEC
5 Sep 19